INGLES MARKETS INC-CLASS A (IMKTA) Fundamental Analysis & Valuation

NASDAQ:IMKTA • US4570301048

Current stock price

88.53 USD
+2.14 (+2.48%)
At close:
88 USD
-0.53 (-0.6%)
After Hours:

This IMKTA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. IMKTA Profitability Analysis

1.1 Basic Checks

  • In the past year IMKTA was profitable.
  • In the past year IMKTA had a positive cash flow from operations.
  • IMKTA had positive earnings in each of the past 5 years.
  • IMKTA had a positive operating cash flow in each of the past 5 years.
IMKTA Yearly Net Income VS EBIT VS OCF VS FCFIMKTA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

1.2 Ratios

  • With a Return On Assets value of 3.70%, IMKTA perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
  • IMKTA has a Return On Equity of 5.80%. This is in the lower half of the industry: IMKTA underperforms 63.16% of its industry peers.
  • IMKTA has a Return On Invested Capital of 4.46%. This is comparable to the rest of the industry: IMKTA outperforms 42.11% of its industry peers.
Industry RankSector Rank
ROA 3.7%
ROE 5.8%
ROIC 4.46%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IMKTA Yearly ROA, ROE, ROICIMKTA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

1.3 Margins

  • Looking at the Profit Margin, with a value of 1.76%, IMKTA is in line with its industry, outperforming 55.26% of the companies in the same industry.
  • In the last couple of years the Profit Margin of IMKTA has declined.
  • IMKTA's Operating Margin of 2.47% is in line compared to the rest of the industry. IMKTA outperforms 55.26% of its industry peers.
  • IMKTA's Operating Margin has declined in the last couple of years.
  • IMKTA has a Gross Margin of 24.13%. This is comparable to the rest of the industry: IMKTA outperforms 50.00% of its industry peers.
  • IMKTA's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 2.47%
PM (TTM) 1.76%
GM 24.13%
OM growth 3Y-31.14%
OM growth 5Y-18.48%
PM growth 3Y-31.16%
PM growth 5Y-16.56%
GM growth 3Y-1.42%
GM growth 5Y-1.67%
IMKTA Yearly Profit, Operating, Gross MarginsIMKTA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. IMKTA Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), IMKTA is destroying value.
  • There is no outstanding debt for IMKTA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
IMKTA Yearly Shares OutstandingIMKTA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
IMKTA Yearly Total Debt VS Total AssetsIMKTA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

  • IMKTA has an Altman-Z score of 4.57. This indicates that IMKTA is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 4.57, IMKTA is in the better half of the industry, outperforming 65.79% of the companies in the same industry.
  • IMKTA has a debt to FCF ratio of 4.17. This is a neutral value as IMKTA would need 4.17 years to pay back of all of its debts.
  • IMKTA has a better Debt to FCF ratio (4.17) than 60.53% of its industry peers.
  • IMKTA has a Debt/Equity ratio of 0.30. This is a healthy value indicating a solid balance between debt and equity.
  • IMKTA has a Debt to Equity ratio of 0.30. This is in the better half of the industry: IMKTA outperforms 65.79% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 4.17
Altman-Z 4.57
ROIC/WACC0.53
WACC8.47%
IMKTA Yearly LT Debt VS Equity VS FCFIMKTA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.3 Liquidity

  • A Current Ratio of 3.36 indicates that IMKTA has no problem at all paying its short term obligations.
  • IMKTA has a Current ratio of 3.36. This is amongst the best in the industry. IMKTA outperforms 97.37% of its industry peers.
  • A Quick Ratio of 1.69 indicates that IMKTA should not have too much problems paying its short term obligations.
  • IMKTA has a Quick ratio of 1.69. This is amongst the best in the industry. IMKTA outperforms 86.84% of its industry peers.
Industry RankSector Rank
Current Ratio 3.36
Quick Ratio 1.69
IMKTA Yearly Current Assets VS Current LiabilitesIMKTA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. IMKTA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 20.98% over the past year.
  • The earnings per share for IMKTA have been decreasing by -12.98% on average. This is quite bad
  • The Revenue has decreased by -0.51% in the past year.
  • Measured over the past years, IMKTA shows a small growth in Revenue. The Revenue has been growing by 2.96% on average per year.
EPS 1Y (TTM)20.98%
EPS 3Y-32.58%
EPS 5Y-12.98%
EPS Q2Q%70.11%
Revenue 1Y (TTM)-0.51%
Revenue growth 3Y-2.07%
Revenue growth 5Y2.96%
Sales Q2Q%6.59%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
IMKTA Yearly Revenue VS EstimatesIMKTA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B
IMKTA Yearly EPS VS EstimatesIMKTA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2019 2022 5 10

More info and screens

Find the best growth stocksShow best growing peers

3

4. IMKTA Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 17.67 indicates a rather expensive valuation of IMKTA.
  • Based on the Price/Earnings ratio, IMKTA is valued a bit cheaper than the industry average as 65.79% of the companies are valued more expensively.
  • IMKTA is valuated rather cheaply when we compare the Price/Earnings ratio to 25.71, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 17.67
Fwd PE N/A
IMKTA Price Earnings VS Forward Price EarningsIMKTA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, IMKTA is valued a bit cheaper than the industry average as 73.68% of the companies are valued more expensively.
  • IMKTA's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. IMKTA is cheaper than 76.32% of the companies in the same industry.
Industry RankSector Rank
P/FCF 13.66
EV/EBITDA 7.16
IMKTA Per share dataIMKTA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150 200 250

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. IMKTA Dividend Analysis

5.1 Amount

  • With a yearly dividend of 0.76%, IMKTA is not a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 0.70, IMKTA pays a bit more dividend than its industry peers.
  • With a Dividend Yield of 0.76, IMKTA pays less dividend than the S&P500 average, which is at 1.91.
Industry RankSector Rank
Dividend Yield 0.76%

5.2 History

  • The dividend of IMKTA has a limited annual growth rate of 0.12%.
  • IMKTA has been paying a dividend for at least 10 years, so it has a reliable track record.
  • IMKTA has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)0.12%
Div Incr Years0
Div Non Decr Years11
IMKTA Yearly Dividends per shareIMKTA Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6

5.3 Sustainability

  • IMKTA pays out 12.90% of its income as dividend. This is a sustainable payout ratio.
DP12.9%
EPS Next 2YN/A
EPS Next 3YN/A
IMKTA Yearly Income VS Free CF VS DividendIMKTA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
IMKTA Dividend Payout.IMKTA Dividend Payout, showing the Payout Ratio.IMKTA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

IMKTA Fundamentals: All Metrics, Ratios and Statistics

INGLES MARKETS INC-CLASS A

NASDAQ:IMKTA (3/13/2026, 8:00:02 PM)

After market: 88 -0.53 (-0.6%)

88.53

+2.14 (+2.48%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)02-05
Earnings (Next)05-06
Inst Owners94.86%
Inst Owner Change-0.92%
Ins Owners0.08%
Ins Owner Change0%
Market Cap1.68B
Revenue(TTM)5.42B
Net Income(TTM)95.13M
Analysts84.44
Price TargetN/A
Short Float %6.51%
Short Ratio7.25
Dividend
Industry RankSector Rank
Dividend Yield 0.76%
Yearly Dividend0.65
Dividend Growth(5Y)0.12%
DP12.9%
Div Incr Years0
Div Non Decr Years11
Ex-Date01-08
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 17.67
Fwd PE N/A
P/S 0.31
P/FCF 13.66
P/OCF 7.12
P/B 1.02
P/tB 1.02
EV/EBITDA 7.16
EPS(TTM)5.01
EY5.66%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)6.48
FCFY7.32%
OCF(TTM)12.44
OCFY14.05%
SpS285.36
BVpS86.39
TBVpS86.39
PEG (NY)N/A
PEG (5Y)N/A
Graham Number98.68
Profitability
Industry RankSector Rank
ROA 3.7%
ROE 5.8%
ROCE 5.87%
ROIC 4.46%
ROICexc 5.3%
ROICexgc 5.3%
OM 2.47%
PM (TTM) 1.76%
GM 24.13%
FCFM 2.27%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-31.14%
OM growth 5Y-18.48%
PM growth 3Y-31.16%
PM growth 5Y-16.56%
GM growth 3Y-1.42%
GM growth 5Y-1.67%
F-Score7
Asset Turnover2.11
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 4.17
Debt/EBITDA 1.93
Cap/Depr 92.5%
Cap/Sales 2.09%
Interest Coverage 250
Cash Conversion 92.19%
Profit Quality 129.37%
Current Ratio 3.36
Quick Ratio 1.69
Altman-Z 4.57
F-Score7
WACC8.47%
ROIC/WACC0.53
Cap/Depr(3y)138.74%
Cap/Depr(5y)127.56%
Cap/Sales(3y)2.94%
Cap/Sales(5y)2.75%
Profit Quality(3y)46.78%
Profit Quality(5y)57.46%
High Growth Momentum
Growth
EPS 1Y (TTM)20.98%
EPS 3Y-32.58%
EPS 5Y-12.98%
EPS Q2Q%70.11%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.51%
Revenue growth 3Y-2.07%
Revenue growth 5Y2.96%
Sales Q2Q%6.59%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-0.36%
EBIT growth 3Y-32.56%
EBIT growth 5Y-16.06%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y160.56%
FCF growth 3Y-43.53%
FCF growth 5Y-29.5%
OCF growth 1Y5.1%
OCF growth 3Y-23.15%
OCF growth 5Y-15.14%

INGLES MARKETS INC-CLASS A / IMKTA Fundamental Analysis FAQ

What is the fundamental rating for IMKTA stock?

ChartMill assigns a fundamental rating of 4 / 10 to IMKTA.


What is the valuation status for IMKTA stock?

ChartMill assigns a valuation rating of 3 / 10 to INGLES MARKETS INC-CLASS A (IMKTA). This can be considered as Overvalued.


How profitable is INGLES MARKETS INC-CLASS A (IMKTA) stock?

INGLES MARKETS INC-CLASS A (IMKTA) has a profitability rating of 3 / 10.


What is the valuation of INGLES MARKETS INC-CLASS A based on its PE and PB ratios?

The Price/Earnings (PE) ratio for INGLES MARKETS INC-CLASS A (IMKTA) is 17.67 and the Price/Book (PB) ratio is 1.02.


How financially healthy is INGLES MARKETS INC-CLASS A?

The financial health rating of INGLES MARKETS INC-CLASS A (IMKTA) is 7 / 10.